Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15243538.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Scleromyxedema is a generalized, papular, and sclerodermoid form of lichen myxedematosus associated with monoclonal gammopathy and systemic changes. Despite anecdotal reports of success with various agents, no satisfactory treatments are currently available. We report 3 adult patients with recalcitrant scleromyxedema associated with paraproteinemia who were treated with thalidomide. All 3 patients had marked improvement of the skin lesions and joint mobility after the first 2 months of therapy, with further amelioration after 4 months, and reduction in paraprotein levels.
Medical subject headings
- Lichenoid Eruptions
- Scleroderma, Systemic
- Thalidomide